SYK Share Price Performance
US$0
-381.01 (-100.00%)
Price US$0
Fair ValueUS$389.24
Share Pricen/a
Narrative Update • May 31
Stryker Corporation Stock Price
- 2 Narratives written by author
- 1 Comments on narratives written by author
- 112 Fair Values set on narratives written by author
SYK Community Narratives
AN
Fair Value
·Fair Value US$389.24 24.2% undervalued intrinsic discount
Aging Populations And Emerging Markets Will Transform Healthcare
2users have liked this narrative
1users have commented on this narrative
49users have followed this narrative
TO
Fair Value
·Fair Value US$323.52 8.8% undervalued intrinsic discount
Investing in Stryker (SYK) should be an easy ride
5users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
Investing in Stryker (SYK) should be an easy ride
Stryker looks like a steady medical-products business that has bounced back after the pandemic and is now expected to keep growing. The big question is whether it can keep delivering stronger cash generation over the next few years while headlines about insider selling distract from the bigger picture.Read more
Aging Populations And Emerging Markets Will Transform Healthcare
Stryker could ride a long wave of demand as people live longer and need more joint and nerve-related procedures, while hospitals shift toward less invasive care where it already sells key tools and services. The bigger question is whether global approvals, supply disruptions, and pressure from government-backed pricing can slow that growth and squeeze profits.Read more
AN
US$389.24
24.2% undervalued intrinsic discount
Fair Value
Revenue
8.84% p.a.
Profit Margin
20.01%
Future PE
28.87x
Price in 2029
US$487.03
Trending Discussion
Recently Updated Narratives
TO
Investing in Stryker (SYK) should be an easy ride
Fair Value: US$323.52 8.8% undervalued intrinsic discount
8 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
SYK: Hospital Digitization And Cyber Resilience Will Drive 2026 Rebound Potential
Fair Value: US$389.24 24.2% undervalued intrinsic discount
49 fair values setusers have set this as their fair value
1 commentusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Solid track record with adequate balance sheet and pays a dividend.
2 Risks
4 Rewards
Stryker Corporation Key Details
About SYK
- Founded
- 1941
- Employees
- 56000
- CEO
- WebsiteView website
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
